{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:05:04Z","timestamp":1759741504220},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2018,7,2]],"date-time":"2018-07-02T00:00:00Z","timestamp":1530489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9,1]]},"DOI":"10.1093\/jjco\/hyy095","type":"journal-article","created":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T11:12:12Z","timestamp":1528715532000},"page":"794-798","source":"Crossref","is-referenced-by-count":5,"title":["Clinicopathologic features and<i>BRCA<\/i>mutations in primary fallopian tube cancer in Japanese women"],"prefix":"10.1093","volume":"48","author":[{"given":"Shoko","family":"Sakurada","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, Sendai, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoh","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Tohoku Medical and Pharmaceutical University, Sendai, Japan"},{"name":"Clinical Research, Innovation and Education Center, Tohoku University Hospital, Sendai, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Tokunaga","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, Sendai, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiaki","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Clinical Research, Innovation and Education Center, Tohoku University Hospital, Sendai, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekazu","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Miyagi Cancer Center, Sendai, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Takehara","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Shikoku Cancer Center, Matsuyama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuo","family":"Yaegashi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, Sendai, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,7,2]]},"reference":[{"key":"key\n\t\t\t\t2018110900253643400_hyy095C1","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.humpath.2011.03.003","article-title":"Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer. Shifting the paradigm","volume":"42","author":"Kurman","year":"2011","journal-title":"Hum Pathol"},{"key":"key\n\t\t\t\t2018110900253643400_hyy095C2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/his.12046","article-title":"Fallopian tube precursors of ovarian low- and high-grade serous neoplasms","volume":"62","author":"Vang","year":"2013","journal-title":"Histopathology"},{"key":"key\n\t\t\t\t2018110900253643400_hyy095C3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1006\/gyno.1997.4844","article-title":"High frequency of BRCA1 and BRCA2 germline mutations in Ashkenazi Jewish ovarian cancer patients, regardless of family history","volume":"67","author":"Beller","year":"1997","journal-title":"Gynecol Oncol"},{"key":"key\n\t\t\t\t2018110900253643400_hyy095C4","first-page":"3193","article-title":"Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers","volume":"58","author":"Rhei","year":"1998","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t2018110900253643400_hyy095C5","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/jnci\/86.17.1336","article-title":"Ovarian cancer incidence among Asian migrants to the United States and their descendants","volume":"86","author":"Herrinton","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t2018110900253643400_hyy095C6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1525-1438.2006.00292.x","article-title":"A 10-year review of primary fallopian tube cancer at a community hospital: a high association of synchronous and metachronous cancers","volume":"16","author":"Benott","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"key\n\t\t\t\t2018110900253643400_hyy095C7","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/00004347-200110000-00009","article-title":"Clinicopathologic and immunohistochemical features and microsatellite status of endometrial cancer of the uterine isthmus","volume":"20","author":"Watanabe","year":"2001","journal-title":"Int J Gynecol Pathol"},{"key":"key\n\t\t\t\t2018110900253643400_hyy095C8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/gcc.22507","article-title":"Identification of somatic genetic alterations in ovarian clear cell carcinoma with next generation sequencing","volume":"57","author":"Shibuya","year":"2018","journal-title":"Genes Chromosomes Cancer"},{"key":"key\n\t\t\t\t2018110900253643400_hyy095C9","doi-asserted-by":"crossref","first-page":"E1200","DOI":"10.1002\/humu.21202","article-title":"Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study","volume":"31","author":"Borg","year":"2010","journal-title":"Hum Mutat"},{"key":"key\n\t\t\t\t2018110900253643400_hyy095C10","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ijc.10970","article-title":"Sociodemographic determinants of incidence of primary fallopian tube carcinoma, Finland 1953\u201397","volume":"104","author":"Riska","year":"2003","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t2018110900253643400_hyy095C11","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ygyno.2007.09.018","article-title":"The incidence of primary fallopian tube cancer in the United States","volume":"107","author":"Stewart","year":"2007","journal-title":"Gynecol Oncol"},{"key":"key\n\t\t\t\t2018110900253643400_hyy095C12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ygyno.2009.06.025","article-title":"Primary fallopian tube carcinoma: results of a retrospective analysis of 64 patients","volume":"115","author":"Pectasides","year":"2009","journal-title":"Gynecol Oncol"},{"key":"key\n\t\t\t\t2018110900253643400_hyy095C13","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/IGC.0000000000000648","article-title":"Primary fallopian tube carcinoma: a single-institution experience of 101 cases","volume":"26","author":"Bao","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"key\n\t\t\t\t2018110900253643400_hyy095C14","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1002\/1097-0142(20001115)89:10<2076::AID-CNCR7>3.0.CO;2-V","article-title":"Carcinoma of the fallopian tube","volume":"89","author":"Baekelandt","year":"2000","journal-title":"Cancer"},{"key":"key\n\t\t\t\t2018110900253643400_hyy095C15","first-page":"89","article-title":"Carcinoma of the fallopian tube","volume":"6","author":"Heintz","year":"2001","journal-title":"J Epidemiol Biostat"},{"key":"key\n\t\t\t\t2018110900253643400_hyy095C16","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/gyno.2002.6743","article-title":"Treatment and survival for women with fallopian tube carcinoma: a population-based study","volume":"86","author":"Kosary","year":"2002","journal-title":"Gynecol Oncol"},{"key":"key\n\t\t\t\t2018110900253643400_hyy095C17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/gyno.1999.5623","article-title":"Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations","volume":"76","author":"Zweemer","year":"2000","journal-title":"Gynecol Oncol"},{"key":"key\n\t\t\t\t2018110900253643400_hyy095C18","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1200\/JCO.2003.04.131","article-title":"Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations","volume":"23","author":"Levine","year":"2003","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2018110900253643400_hyy095C19","author":"National Comprehensive Cancer Network"},{"key":"key\n\t\t\t\t2018110900253643400_hyy095C20","author":"ClinVar"},{"key":"key\n\t\t\t\t2018110900253643400_hyy095C21","first-page":"30021","article-title":"Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations","volume":"18","author":"Wardell","year":"2018","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t2018110900253643400_hyy095C22","doi-asserted-by":"crossref","first-page":"112258","DOI":"10.18632\/oncotarget.22733","article-title":"Prevalence of pathogenic germline variants detected by multigene sequencing in unselected Japanese patients with ovarian cancer","volume":"8","author":"Hirasawa","year":"2017","journal-title":"Oncotarget"},{"key":"key\n\t\t\t\t2018110900253643400_hyy095C23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/gyno.1996.4519","article-title":"Early occurrence and prognostic significance of p53 alteration in primary carcinoma of the fallopian tube","volume":"64","author":"Zheng","year":"1997","journal-title":"Gynecol Oncol"},{"key":"key\n\t\t\t\t2018110900253643400_hyy095C24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000010212","article-title":"Overexpression of p53 and HER-2\/neu and c-myc in primary fallopian tube carcinoma","volume":"49","author":"Chung","year":"2000","journal-title":"Gynecol Obstet Invest"},{"key":"key\n\t\t\t\t2018110900253643400_hyy095C25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3835(00)00335-9","article-title":"p53 expression in fallopian tube carcinomas","volume":"156","author":"Rosen","year":"2000","journal-title":"Cancer Lett"},{"key":"key\n\t\t\t\t2018110900253643400_hyy095C26","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/bjc.1996.510","article-title":"p53 mutation is associated with high S-phase fraction in primary fallopian tube adenocarcinoma","volume":"74","author":"Runnebaum","year":"1996","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t2018110900253643400_hyy095C27","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.humpath.2011.03.003","article-title":"Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer\u2014shifting the paradigm","volume":"42","author":"Kurman","year":"2011","journal-title":"Hum Pathol"},{"key":"key\n\t\t\t\t2018110900253643400_hyy095C28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kinderburger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"key\n\t\t\t\t2018110900253643400_hyy095C29","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/PAS.0b013e3181ef7b16","article-title":"Are all pelvic (nonuterine) serous carcinomas of tubal origin?","volume":"34","author":"Pryzybycin","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"key\n\t\t\t\t2018110900253643400_hyy095C30","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/path.3023","article-title":"TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma\u2014evidence supporting the clonal relationship of the two lesions","volume":"226","author":"Kuhn","year":"2012","journal-title":"J Pathol"},{"key":"key\n\t\t\t\t2018110900253643400_hyy095C31","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1038\/onc.2015.425","article-title":"Transferrin facilitates the formation of DNA double-strand breaks via transferrin receptor 1: the possible involvement of transferrin in carcinogenesis of high-grade serous ovarian cancer","volume":"35","author":"Shigeta","year":"2016","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t2018110900253643400_hyy095C32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.18632\/oncotarget.12306","article-title":"Prognostic significance of BRCA mutations in ovarian cancer: an updated systematic review with meta-analysis","volume":"8","author":"Xu","year":"2017","journal-title":"Oncotarget"},{"key":"key\n\t\t\t\t2018110900253643400_hyy095C33","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03445","article-title":"Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy","volume":"14","author":"Farmer","year":"2005","journal-title":"Nature"},{"key":"key\n\t\t\t\t2018110900253643400_hyy095C34","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00280-018-3532-9","article-title":"PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer","volume":"81","author":"Morgan","year":"2018","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jjco\/article-pdf\/48\/9\/794\/26446679\/hyy095.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T09:14:48Z","timestamp":1604394888000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/48\/9\/794\/5047926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,2]]},"references-count":34,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,7,2]]},"published-print":{"date-parts":[[2018,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyy095","relation":{},"ISSN":["1465-3621"],"issn-type":[{"value":"1465-3621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,9]]},"published":{"date-parts":[[2018,7,2]]}}}